Synopsis: TANFAC Industries Limited has successfully raised Rs. 250 crore through a Qualified Institutional Placement (QIP) to fund its HFC-32 refrigerant gas project, expand fluorochemical capacities, and strengthen backward integration. The company has also secured long-term supply arrangements worth approximately Rs. 3,612 crore with global customers, providing strong revenue visibility.
Shares of TANFAC Industries Limited are likely to remain in focus after the company announced the successful completion of a Rs. 250 crore Qualified Institutional Placement (QIP) aimed at accelerating its long-term expansion plans in the fluorochemicals business.
TANFAC Industries Limited has a total market capitalization of approximately Rs. 5,262.04 crore. The company’s shares were trading at Rs. 2504.90 apiece on the stock exchange, up by 0.87 percent during the session. The stock has gained 6.60 percent over the last five trading sessions, while it has gained 21.45 percent over the last month. The stock touched a 52-week high of Rs. 2585 and a 52-week low of Rs. 1632.60.
According to the company’s press release, TANFAC raised Rs. 250 crore through a Qualified Institutional Placement, marking its first equity capital raise in more than three decades. The issue was priced at Rs. 1,985.83 per share, representing a 5 percent discount to the regulatory floor price of Rs. 2,090.34. The QIP witnessed participation from several marquee institutional investors, including Motilal Oswal (Mutual Fund & AIF), Malabar Investments, 360 ONE, Niveshaay Funds, and Bengal Finance & Investment, reflecting strong institutional confidence in the company’s long-term growth prospects.
The proceeds from the fund raise will primarily be utilized to establish a new HFC-32 refrigerant gas manufacturing plant, expand downstream fluorochemical capacities, strengthen backward integration through higher hydrofluoric acid and sulphuric acid production, and meet general corporate requirements. These investments are expected to improve raw material security, enhance operating efficiencies, and support margin expansion.
The company also highlighted that it has already secured long-term customer commitments worth approximately Rs. 3,612 crore over the next five to seven years. These include an indefinite supply arrangement with one of India’s leading air-conditioning and commercial refrigeration companies valued at around Rs. 61 crore, a 7-year contract with a Japanese customer worth approximately Rs. 2,362 crore, and a 5-year memorandum of understanding with a multinational company valued at around Rs. 1,250 crore.
The expansion comes at a time when global demand for fluorochemicals and next-generation refrigerant gases is rising, supported by stricter environmental regulations, increasing adoption of energy-efficient cooling systems, and the gradual transition toward low-global-warming-potential refrigerants. HFC-32 has emerged as one of the preferred refrigerants in residential and commercial air-conditioning systems due to its superior energy efficiency and lower environmental impact compared to conventional refrigerants.
For investors, the successful QIP significantly strengthens TANFAC’s balance sheet while providing the capital required to execute its expansion strategy. Coupled with multi-year customer contracts worth over Rs. 3,600 crore, the company has improved revenue visibility and is well positioned to capitalize on growing global demand for specialty fluorochemicals and refrigerant gases.
Incorporated in 1972, TANFAC Industries Limited is one of India’s leading manufacturers of hydrofluoric acid and fluorine-based specialty chemicals. The company produces hydrofluoric acid, sulphuric acid, potassium fluoride, potassium bifluoride, and other fluorochemical products catering to domestic and international markets.
The successful Rs. 250 crore QIP, along with long-term customer contracts worth approximately Rs. 3,612 crore, marks a significant milestone in TANFAC’s growth journey and reinforces its ambitions to become a larger player in the high-value global fluorochemicals market.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of decisions based on this article. Please consult your investment advisor before investing.
